Administration of Truncated Secretory Leukoprotease Inhibitor Ameliorates Bleomycin-induced Pulmonary Fibrosis in Hamster

American Journal of Respiratory and Critical Care Medicine

Volumn 153, Issue 1, 1996, Pages 369-374

  Mitsuhashi, Hiroaki ^a   Asano, Satoshi ^a   Nonaka, Takashi ^a   Hamamura, Ichiro ^a   Masuda, Ken Ichi ^a   Kiyoki, Mamoru ^a  

^a TEIJIN LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; FIBROSING ALVEOLITIS; HAMSTER; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALS; BLEOMYCIN; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; CRICETINAE; DATA INTERPRETATION, STATISTICAL; EOSINOPHILS; FLUORESCENCE; LEUKOCYTE ELASTASE; LUNG; LYMPHOCYTE COUNT; MACROPHAGES; MALE; MESOCRICETUS; NEUTROPHILS; PANCREATIC ELASTASE; PROTEINASE INHIBITORY PROTEINS, SECRETORY; PROTEINS; PULMONARY ALVEOLI; PULMONARY FIBROSIS; SERINE PROTEINASE INHIBITORS; TIME FACTORS;

EID: 0030029719     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.153.1.8542145     Document Type: Article

References (27)

1. Snider, G. L., J. A. Hayes, and A. L. Korthy. 1978. Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin. Pathology and stereology. Am. Rev. Respir. Dis. 117:1099-1108.
2. Delena, M., A. Guzzon, S. Monfardini, and G. Bonnadonna. 1972. Clinical, radiological and histopathological studies on pulmonary toxicity induced by treatment with bleomycin. Cancer Chemother. Rep. 56:343-356.
3. Mario, A. L., W. M. B. Carlos, L. Benjamin, and A. S. Philip. 1972. Interstitial pneumonitis associated with bleomycin therapy. Am. J. Clin. Pathol. 58:501-510.
4. Szapiel, S. V., N. A. Elson, J. D. Fulmer, G. W. Hunninghake, and R. G. Crystal. 1979. Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. Am. Rev. Respir. Dis. 120:893-899.
5. Hesterberg, T. W., J. E. Gerriets, K. M. Reisser, A. C. Jackson, C. E. Cross, J. A. Last. 1981. Bleomycin-induced pulmonary fibrosis: correlation of biochemical, physiological and histological changes. Toxicol. Appl. Pharmacol. 60:360-367.
6. McCullough, B., J. F. Collins, W. G. Johannson, Jr., and F. L. Grover. 1978. Bleomycin-induced diffuse interstitial pulmonary fibrosis in baboon. J. Clin. Invest. 61:79-88.
7. Jones, A. W., and N. L. Reeve. 1978. Ultrastructural study of bleomycin-induced pulmonary changes in mice. J. Pathol. 124:227-233.
8. Shen, A. S., C. Haslett, D. C. Feldsien, P. T. Henson, and R. M. Cherniack. 1988. The intensity of chronic lung inflammation and fibrosis after bleomycin is directly related to the severity of acute injury. Am. Rev. Respir. Dis. 137:564-571.
9. Crystal, R. G., P. B. Bitterman, S. I. Rennard, A. J. Hance, and B. A. Keogh. 1984. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. N. Engl. J. Med. 310:154-166, 235-244.
10. Thrall, R. S., S. M. Phan, J. R. McCormick, and P. A. Ward. 1981. The development of bleomycin induced pulmonary fibrosis in neutrophil-depleted and complement-depleted rats. Am. J. Pathol. 195:76-81.
11. Clark, J. G., and C. Kuhn, III. 1982. Bleomycin-induced pulmonary fibrosis in hamsters: effect of neutrophil depletion on lung collagen synthesis. Am. Rev. Respir. Dis. 126:737-739.
12. Phan, S. H., D. Schrier, B. McGarry, and R. E. Duque. 1983. Effect of the beige mutation on bleomycin-induced pulmonary fibrosis in mice. Am. Rev. Respir. Dis. 127:456-459.
13. Weiss, S. J. 1989. Tissue destruction by neutrophils. N. Engl. J. Med. 320:3665-3676.
14. Cantin, A. M., S. L. North, G. A. Fells, R. C. Hubbard, and R. G. Crystal. 1987. Oxidant-mediated epithelial cell injury in ideopathic pulmonary fibrosis. J. Clin. Invest. 79:1665-1673.
15. Nagai, A., K. Aoshiba, Y. Ishihara, H. Inao, K. Sakamoto, E. Yamaguchi, J. Kagawa, and T. Takizawa. 1992. Administration of α-proteinase inhibitor ameliorates bleomycin-induced pulmonary fibrosis in hamsters. Am. Rev. Respir. Dis. 145:651-656.
16. Masuda, K., T. Suga, A. Takeuti, M. Kanesaki, A. Imaizumi, and Y. Suzuki. 1994. Specific cleavage of secretory leukoprotease inhibitor by neutrophil elastase and saliva. Biochem. Pharmacol. 48:651-657.
17. Masuda, K., A. Imaizumi, T. Kamimura, K. Watanabe, T. Sugiyama, Y. Suzuki, and E. Ohtsuka. 1992. Expression of the C-terminal domain of secretory leukoprotease inhibitor in E. coli as a thrombin-cleavable fusion protein (abstract). Am. Rev. Respir. Dis. 145:A200.
18. Barry, T. P., I. Steven, M. Cassandra, D. G. Lynn, and B. C. Allen. 1990. A modified bronchoalveolar procedure that allows measurement of lung epithelial lining fluid volume. Am. Rev. Respir. Dis. 141:314-320.
19. Ashcroft, T., J. M. Simpson, and V. Timbrell. 1988. Simple method of estimating severity of pulmonary fibrosis on numerical scale. J. Clin. Pathol. 41:467-470.
20. Mario, J. C., N. Kiichiro, Z. Morris, and C. R. James. 1979. Sensitive substractes for human leukocyte and pancreatic elastase: a study of the merits of various chromophoric and fluorogenic leaving groups in assay for serine proteases. Anal. Biochem. 99:53-64.
21. Gillissen, A., P. Birrer, N. G. Mcelvaney, R. Buhl, C. Vogelmeier, R. F. Hoyt, R. C. Hubbard, and R. G. Crystal. 1993. Recombinant secretory leukoprotease inhibitor augments glutathione levels in lung epithelial lining fluids. J. Appl. Physiol. 75:825-832.
22. Chandler, D. B., and J. D. Fulmer. 1985. The effect of deferoxamine on bleomycin-induced lung fibrosis in the hamster. Am. Rev. Respir. Dis. 131:596-598.
23. Scher, W. 1987. Biology of disease: the role of extracellular proteases in cell proliferation and differentiation. Lab. Invest. 57:607-633.
24. Okunishi, H., M. Miyazaki, T. Okamura, and N. Toda. 1984. Evidence for a putatively new angiotensin II-generating enzyme in the vascular wall. J. Hypertens. 2:277-284.
25. 107) of elastase and cathepsin G activities: consequence for neutrophil-platelet cooperation. Br. J. Pharmacol. 108:1100-1106.
26. Johnson, D. E., and M. K. Georgieff. 1989. Pulmonary neuroendocrine cells. Their secretory products and their potential roles in health and chronic lung disease in infancy. Am. Rev. Respir. Dis. 140: 1807-1812.
27. Mullaney, P., B. Curren, L. Collum, and S. Kilfeather. 1991. Fibroblast and endothelial outgrowth from human Tenon's explants: inhibition of fibroblast growth by 5HT receptor antagonism. Res. Commun. Chem. Pathol. Pharmacol. 74:201-213.